Literature DB >> 1002408

Skeletal demineralization and growth retardation in inflammatory bowel disease.

H K Genant, J C Mall, J B Wagonfeld, J V Horst, L H Lanzi.   

Abstract

Skeletal growth and mineralization in 54 adolescent and adult patients with inflammatory bowel disease have been analyzed comprehensively. Quantitative and qualitative radiologic techniques consisted of conventional roentgenography, photon absorptiometry, and radiographic morphometry. The data are correlated with the type, duration, and severity of disease, and with several modes of therapy. The results indicate the osteopenia and retardation of growth are common in patients with inflammatory bowel disease, particularly in adolescents, in whom the effects of corticosteroids on the skeleton are most deleterious.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1002408     DOI: 10.1097/00004424-197611000-00007

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  9 in total

1.  Reduced bone density in patients with inflammatory bowel disease.

Authors:  I Bjarnason; A Macpherson; C Mackintosh; M Buxton-Thomas; I Forgacs; C Moniz
Journal:  Gut       Date:  1997-02       Impact factor: 23.059

2.  Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease.

Authors:  R J Motley; E O Crawley; C Evans; J Rhodes; J E Compston
Journal:  Gut       Date:  1988-10       Impact factor: 23.059

3.  Adalimumab Therapy Has a Beneficial Effect on Bone Metabolism in Patients with Crohn's Disease.

Authors:  Sundaram G Veerappan; Martin Healy; Bernard J Walsh; Colm A O'Morain; Jacqueline S Daly; Barbara M Ryan
Journal:  Dig Dis Sci       Date:  2015-03-03       Impact factor: 3.199

4.  Bone mineral density and nutritional status in children with chronic inflammatory bowel disease.

Authors:  A M Boot; J Bouquet; E P Krenning; S M de Muinck Keizer-Schrama
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

5.  Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease.

Authors:  P I Croucher; S Vedi; R J Motley; N J Garrahan; M R Stanton; J E Compston
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

6.  Osteoporosis in patients with inflammatory bowel disease.

Authors:  J E Compston; D Judd; E O Crawley; W D Evans; C Evans; H A Church; E M Reid; J Rhodes
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

7.  Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease.

Authors:  D Clements; J E Compston; W D Evans; J Rhodes
Journal:  Gut       Date:  1993-11       Impact factor: 23.059

Review 8.  Juvenile spondyloarthropathies: clinical manifestations and medical imaging.

Authors:  E M Azouz; C M Duffy
Journal:  Skeletal Radiol       Date:  1995-08       Impact factor: 2.199

9.  Risk factors for osteoporosis in Japan: is it associated with Helicobacter pylori?

Authors:  Daisuke Asaoka; Akihito Nagahara; Yuji Shimada; Kenshi Matsumoto; Hiroya Ueyama; Kohei Matsumoto; Yuta Nakagawa; Tsutomu Takeda; Ippei Tanaka; Hitoshi Sasaki; Taro Osada; Mariko Hojo; Sumio Watanabe
Journal:  Ther Clin Risk Manag       Date:  2015-03-06       Impact factor: 2.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.